EBITDA's not as impressive as the NPAT, which is unusual... the R&D Tax Credit of about $6m means we have $9.3m NPAT, but only $3.7m EBITDA.
The maiden profit is a little more tempered with that info, but still, none of us are buying for the 2023 profit. The growth potential is excellent. Would've loved a projected FY24 somewhere in there.
EBITDA's not as impressive as the NPAT, which is unusual... the...
Add DRO (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$2.01 |
Change
0.080(4.15%) |
Mkt cap ! $1.532B | |||
| Open | High | Low | Value | Volume |
| $1.98 | $2.03 | $1.88 | $37.37M | 18.93M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 10000 | $2.01 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $2.02 | 230725 | 9 |
View Market Depth
| Last trade - 16.10pm 04/07/2024 (20 minute delay) ? |
| DRO (ASX) Chart |